Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Generic medicines

New legislation passed to prevent excessive price hiking of generic drugs

Houses of Parliament building

Source: ChameleonsEye / Shutterstock

New law gives the government the power to make pharmaceutical companies cut “unreasonable” prices for generic drugs

A new law which aims to bring tougher price control to unbranded generic drugs received Royal Assent in the House of Commons on 27 April 2017.

The Health Service Medical Supplies (Costs) Act gives the government the power to instruct pharmaceutical companies to reduce the price of a generic medicine or introduce other controls on their branded products in cases where it thinks drug companies are charging “unreasonable” prices for generics.

Manufacturers could face financial penalties if they fail to comply with the new law.

The government has traditionally relied on the market to keep generic costs down but in cases where there is no competition, prices have been hiked, according to the Department of Health briefing paper on the new legislation.

The intention is for the department to work with industry representatives and the Competition and Markets Authority to determine when a price is “unreasonably high”. The new legislation will also give the government more powers to collect information about the sale of drugs.

The Health Service Medical Supplies (Costs) Act was among a raft of bills which were granted Royal Assent on 27 April, before the dissolution of Parliament on 3 May 2017 ahead of the 8 June 2017 UK general election.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20202701

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Paediatric Drug Handling

    Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

    £33.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Houses of Parliament building

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.